BALA CYNWYD, Pa., Feb 2, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Solutia, Inc. ("Solutia" or the "Company") (NYSE - SOA) relating to the proposed acquisition by Eastman Chemical ("Eastman").

Under the terms of the transaction, Solutia shareholders would receive $22.00 in cash and 0.12 of Eastman common stock for each share of Solutia stock they own. The transaction values Solutia at approximately $27.65 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Solutia for not acting in the Company's shareholders' best interests in connection with the sale process to Eastman. The transaction may undervalue Solutia as Solutia generated 30% of its revenue from Asia-Pacific countries in 2010 and expects to grow by a third by 2015. In addition, an analyst has set a price target of $28.00 per share of Solutia stock and the company traded at $27.85 on February 2, 2012.

If you own shares of Solutia stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/380-soa-solutia-inc.html, or by calling toll free 877-LEGAL-90.

SOURCE Brodsky & Smith, LLC